On Monday, Colgate-Palmolive Company (NYSE:CL)’s shares declined -1.18% to $68.46.
On April 16, Colgate-Palmolive Company (CL), will provide a live webcast of its 2015 first quarter earnings conference call on Thursday, April 30, 2015 at 11:00 a.m. ET. The call will be hosted by Chairman, President and CEO, Ian Cook, and Senior Vice President - Investor Relations, Bina Thompson.
Colgate-Palmolive Company, together with its auxiliaries, manufactures and markets consumer products worldwide. It operates in two segments: Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, counting toothpastes, toothbrushes, and mouthwashes, in addition to pharmaceutical products for dentists and other oral health professionals; personal care products comprising liquid hand soaps, shower gels, bar soaps, deodorants, antiperspirants, shampoos, and conditioners; and home care products, such as dishwashing liquids, laundry and dishwashing detergents, household cleaners, oil soaps, bleaches, fabric conditioners, and other products.
Apollo Education Group Inc (NASDAQ:APOL)’s shares dropped -1.18% to $17.61, during the last trading session on Monday.
On April 8, Carnegie Learning, Inc., a partner of Apollo Education Group, Inc. (NASDAQ: APOL), declared that the Florida State Board of Education has approved Carnegie Learning’s middle school and Algebra I programs for use across the state. These programs comprise Carnegie Learning’s Middle School Math Series Courses 1, 2, and Pre-Algebra for grades 6-8, as well as its Algebra I program, which may be used in both middle and high schools. The approved Carnegie Learning programs meet all Mathematics Florida Standards and are now accessible right away to all Florida middle and high schools.
“A sound foundation in mathematics is a critical element for students preparing to meet the challenges of our 21st century workforce,” said Erin Simmons, chief operating officer at Carnegie Learning. “We are proud to assist bring Carnegie Learning’s blended math curricula into classrooms across Florida to provide students with a learning environment that will assist them build and grow their math skills.”
Carnegie Learning offers a learning environment that extends beyond traditional textbook learning. Based on more than 20 years of research into how students process and learn mathematical principles, Carnegie Learning blends consumable, write-in textbooks with adaptive digital, online tools and resources to create a personalized learning path for each student.
Apollo Education Group, Inc. provides private education services. It offers online and on-campus undergraduate, graduate, professional development, and other non-degree educational programs and services primarily to working learners in the United States and internationally. The company operates in University of Phoenix, Apollo Global, and Other segments.
At the end of Monday’s trade, Boston Scientific Corporation (NYSE:BSX)‘s shares dipped -1.14% to $18.19.
Yesterday, the Journal of the American College of Cardiology published data confirming the long-term safety and efficacy of the Boston Scientific Corporation (BSX) S-ICD System™ (subcutaneous implantable defibrillator) for patients at risk of sudden cardiac arrest.
The study, “Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-year Results from a Pooled Analysis of the IDE Study and EFFORTLESS Registry” was led by Dr. Martin Burke, professor of medicine at the University of Chicago. The analysis combined data from two large S-ICD studies to provide the most comprehensive look at S-ICD System patient outcomes to date.
The S-ICD System – which was approved by the Food & Drug Administration (FDA) in 2012 and which gained Category 1 CPT Codes in January – was shown to be highly effective, converting more than 98 percent of heart arrhythmias that can lead to sudden death. These data are comparable to efficacy outcomes found in transvenous ICD (TV-ICD) clinical trials (95-99%)1-4.
This study combined data from the U.S. Investigational Device Exemption study that led to the device’s approval by the FDA and also data from the EFFORTLESS registry, each with extended follow-up (average 22 months) relative to formerly published reports on the S-ICD System.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Administration, and MedSurg. It offers interventional cardiology products, counting coronary stent systems used in the treatment of coronary artery disease; coronary technology products to treat atherosclerosis; intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, in addition to peripheral vessels; and structural heart therapy systems.
AEGON N.V. (ADR) (NYSE:AEG), ended its Monday’s trading session with -1.14% loss, and closed at $7.82.
On April 8, AEGON N.V. (ADR) (AEG), published the agenda for its Annual General Meeting of Shareholders (AGM), on Wednesday, May 20, 2015.
The agenda comprises a proposal to reappoint Mr. A.R. (Alex) Wynaendts as Aegon’s CEO for a new four-year term. The Supervisory Board proposes to reappoint Mr. Wynaendts in view of his broad international and financial services experience, his leadership and vision and his performance as CEO. Through redefining Aegon’s purpose, Mr. Wynaendts has ensured serving and better connecting with customers is at the heart of Aegon’s strategy. Furthermore, he has positioned Aegon to benefit from opportunities in the market, with a strong capital position and healthy cash flows leading to a sustainable growing dividend.
Mr. Wynaendts (1960) joined Aegon in 1997. He became CEO and Chairman of Aegon’s Executive Board in April 2008, and was redesignated at the 2011 AGM.
Further details of the projected (re)appointments can be found in the AGM agenda, which also comprises a proposal to approve the Annual Accounts 2014 and a proposal to approve the final dividend for 2014 of EUR 0.12 per share, bringing the total dividend to EUR 0.23 per share.
Aegon N.V. provides life insurance, pensions, and asset administration services. The company operates through the Americas, the Netherlands, the United Kingdom, and New Markets. The company offers life and protection products, such as traditional and universal life, endowment, term, and whole life insurance products; and supplemental health, accidental death and dismemberment insurance, critical illness, cancer treatment, credit/disability, income protection, travel, and long-term care insurance.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
